Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment.
Danijela MandićLana NežićLjiljana AmdžićNataša VojinovićRadoslav GajaninMiroslav PopovićJugoslav ĐeriMilena Todorović BalintJelena DumanovićZoran MilovanovićJelica Grujić-MilanovićRanko ŠkrbićVesna JaćevićPublished in: Cancers (2023)
DLBCL might harbor certain molecular signatures such as MRP1/ABCC1, survivin, and BCRP/ABCC2 overexpression that can predict resistance to R-CHOP.